HYD0886BetaGlycerophosphate disodium saltpentah and 17 more items

Virginia Commonwealth University awarded a contract to MedChemExpress LLC on August 4, 2026, for the procurement of specialized research chemicals and biological proteins. The cumulative contract value totals $2,360.80. The awardee will deliver all line items to VCU Procurement in Virginia. The contract encompasses a diverse portfolio of protease inhibitors, growth factors, and research reagents essential for laboratory and biomedical research applications.

The deliverables include chemical inhibitors such as pepstatin, aprotinin, benzamidine hydrochloride, and AEBSF hydrochloride, as well as biochemical reagents including beta-glycerophosphate disodium salt, dapi dihydrochloride solution, and bucladesine sodium. Additionally, the contract specifies procurement of recombinant human proteins, including basic fibroblast growth factor, insulin-like growth factor 1, vascular endothelial growth factor 165, and stem cell factor, with quantities ranging from free samples to 500-microgram units. Several line items include complementary free samples, demonstrating a mixed procurement strategy combining paid product acquisitions with supplier-provided samples to support VCU's research operations.